Celldex Therapeutics reported $153K in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14342M 383M
Agenus AGEN:US $ 252.95M 242.22M
Amgen AMGN:US $ 6706M 180M
Applied Genetic Technologies AGTC:US $ 0M 0.5M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biocept BIOC:US $ 17.47M 5.42M
Bristol Myers Squibb BMY:US $ 11624M 79M
Celldex Therapeutics CLDX:US $ 0.15M 3.33M
Cytrx CYTR:US 0 0
Glaxosmithkline GSK:US $ 9077M 985M
Immunogen IMGN:US $ 9.21M 7.74M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Newlink Genetics NLNK:US $ 0M 0.01M
Northwest Biotherapeutics NWBO:US 350K 66K
Pfizer PFE:US $ 24094M 5117M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Seattle Genetics SGEN:US $ 424.06M 35.58M